The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Cardiome Pharma Corp closed at $5.55.

Over the last five days, shares have lost 1.60% and are down 50.13% for the last year to date. This security has underperformed the S&P TSX by 38.08% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.68
Updated at previous session's close. Delayed by at least 15 minutes.
S&P TSX0.62%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Total other revenue--------
Total revenue5565
Gross profit2454
Total cost of revenue3111
Total operating expense1210138
Selling / general / administrative8886
Research & development0030
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-7-5-7-3
Interest income (expense), net non-operating0-1-1-1
Gain (loss) on sale of assets--------
Income before tax-8-6-7-4
Income after tax-7-6-7-4
Income tax, total0000
Net income-7-6-7-4
Total adjustments to net income--------
Net income before extra. items-7-6-7-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-7-6-7-4
Inc. avail. to common incl. extra. items-7-6-7-4
Diluted net income-7-6-7-4
Dilution adjustment--------
Diluted weighted average shares20191717
Diluted EPS excluding extraordinary itemsvalue per share-0.37-0.31-0.43-0.23
Dividends per sharevalue per share--
Diluted normalized EPSvalue per share-0.37-0.31-0.43-0.23